ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

High Dimensional Analysis of IL-10-Producing Human B Cells and Their Characterization in Operationally Tolerant Transplant Recipients

M. C. Glass, D. Glass, J. Oliveria, B. Mbiribindi, C. Esquivel, S. M. Krams, S. C. Bendall, O. M. Martinez

Stanford University Sch of Med, Stanford, CA

Meeting: 2022 American Transplant Congress

Abstract number: 1225

Keywords: B cells, Tolerance

Topic: Basic Science » Basic Science » 04 - B-cell / Antibody /Autoimmunity

Session Information

Session Name: B-cell / Antibody /Autoimmunity

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Regulatory B cells (Breg) participate in control of alloimmune responses in murine models of graft tolerance and are associated with improved outcomes in clinical transplant recipients. However, our understanding of human Breg characteristics, and the potential to harness them for therapeutic purposes, has been hampered by the reported variability of their phenotype and function. Here we developed a custom mass cytometry panel and pipeline for deep profiling and utilized it to investigate IL-10-producing human B cells.

*Methods: PBMC from healthy donors were stimulated with 11 different cocktails of TLR ligands, anti-CD40 and cytokines to identify optimal conditions for eliciting IL-10-producing human B cells. Immunophenotype and functional features were determined using antibodies against 24 surface and 14 intracellular proteins and analysis by mass cytometry (CyTOF). Live cell tracing was used to map the origin of IL-10-producing B cells. PBMC from healthy donors, transplant recipients and operationally tolerant (OT) transplant recipients were analyzed for IL-10-producing B cells.

*Results: The combination of CpG, anti-CD40, IL-2, IL-21 and IL-35 was most effective in eliciting IL-10-producing B cells (mean=34.1% of CD19+ B cells)). High dimensionality reduction with UMAP revealed that seven previously identified Breg phenotypes including CD19+CD24hiCD38hi and CD19+CD25hiCD71hiCD73– B cells captured some, but not all, IL-10-producing B cells. Live cell tracking indicates that multiple B cell subsets can give rise to IL-10-producing cells but the CD45RB+CD27+ B cell memory subset and the CD24+CD38+ transitional B cell subset yielded the highest proportion of IL-10+ B cells. While B cells that exclusively produced IL-10 could be detected, the majority of IL-10+ B cells also produced TNFα and IL-6 with lesser proportions of IL-10+ B cells also producing IL-4, Granzyme B and the p35 subunit of IL-35. OT transplant recipients and healthy controls had increased IL-10+TNFα– B cells (8% and 10% respectively) compared to transplant recipients (2%). IL-10+ B cells were particularly enriched in CD9+ B cells in OT patients but not in transplant controls.

*Conclusions: Human IL-10-producing B cell are heterogeneous with respect to phenotype and function and can emerge from multiple canonical B cell subsets. OT transplant recipients have increased proportions of IL-10+ B cells compared to transplant recipients on immunosuppression. High dimensional, single cell analysis of human IL-10+ B cells provides important insight for understanding immune regulation in transplantation and for harnessing Breg subsets for therapeutic use.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Glass MC, Glass D, Oliveria J, Mbiribindi B, Esquivel C, Krams SM, Bendall SC, Martinez OM. High Dimensional Analysis of IL-10-Producing Human B Cells and Their Characterization in Operationally Tolerant Transplant Recipients [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/high-dimensional-analysis-of-il-10-producing-human-b-cells-and-their-characterization-in-operationally-tolerant-transplant-recipients/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences